Intake & Induction

This NIDA web page includes facts and figures on addressing substance use disorders in the prison population.

This NIDA resource includes talking points written in plain language as a suggested way to communicate concepts of drug use and addiction to adults or teens.

This NIDA web page includes resources to help decrease substance use, address barriers to care, and improve outcomes among people in jail and prison systems.

This two-page pocket guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

This quick start guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

This fact sheet includes several tips for suggesting that a loved one receive treatment for substance use.

This web page provides frequently asked questions regarding the 2023 Consolidated Appropriations Act, which eliminates the X-waiver (DATA-Waiver) and increases accessibility of medication-assisted treatment (MAT).

This letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).

This compilation of best practice recommendations and resources provides guidance to initiate and expand MAT programs for OUD for patient populations in a variety of service settings.

This report is intended to support state Medicaid agencies and payers in improving access to substance use disorder treatment, quality, and capacity, with a special focus on medication-assisted treatment for opioid use disorder.